MEDIZEN HUMANCARE Inc. (XKON:236340)
1,900.00
+50.00 (2.70%)
At close: Oct 24, 2025
MEDIZEN HUMANCARE Company Description
MEDIZEN HUMANCARE Inc., a research company, engages in the genomic analysis to predict diseases on an individual basis in Asia, the Americas, Europe, and internationally.
Its services include M-CHECK, which provides an analysis of patients’ risk for genetic diseases using genomic variation packages related to specific diseases with gene chips or analysis kits; and MELTHY (DTC), a DNA analysis service.
The company was founded in 2012 and is based in Seoul, South Korea.
MEDIZEN HUMANCARE Inc.
| Country | South Korea |
| Founded | 2012 |
| Industry | Commercial Physical and Biological Research |
Contact Details
Address: PNS Homes Tower, 6 Seoul South Korea | |
| Phone | 82 2 555 9806 |
| Website | medizencare.com |
Stock Details
| Ticker Symbol | 236340 |
| Exchange | Korea New Exchange |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 8731 |